If approved, molnupiravir would become the first oral antiviral medication in the world – a simple pill - for the disease that has ravaged the world since the beginning of last year.,free blackjack games online no download
free slot machine apps that pay real money,The drugmaker has said that the treatment has shown to be effective in halving the risk of death or hospitalisation for those who are most vulnerable to the severe form of COVID-19.
soccer way app,Merck said in a statement that it has filed the application for molnupiravir, which is "an investigational oral antiviral medicine, for the treatment of mild-to-moderate Covid-19 in adults who are at risk for progressing to severe Covid-19 and/or hospitalisation".
Merck said it is working "with regulatory agencies worldwide to submit applications for emergency use or marketing authorisation in the coming months.",cash coaster slot machine
Experts said if the drug is authorised for use, the clinical management of COVID-19 could change as the pill can easily be administered at home.,u.s. open 2021
tennis grip l3,Merck said the pill has shown to be effective against all variants of the SARS-CoV-2 virus, including the highly contagious Delta variant, as per viral sequencing conducted so far.
The drug has been developed by Merck with Ridgeback Biotherapeutics.,spinway
1 xbet,There are several drugs that are currently used in treating COVID-19. These include Gilead Sciences Inc's infused antiviral remdesivir and generic steroid dexamethasone - both are given only to hospitalised patients.
Regeneron Pharmaceuticals Inc and Eli Lilly have also come up with monoclonal antibody drugs for COVID-19 treatment.,free quick hit slot machine